Loading...
Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
The systemic immune‐inflammation index (SII = N × P/L) based on neutrophil (N), platelet (P) and lymphocyte (L) counts is used to predict the survival of patients with malignant tumours and can fully reflect the balance between host inflammatory and immune status. This study is conducted to explore...
Na minha lista:
| Udgivet i: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7077539/ https://ncbi.nlm.nih.gov/pubmed/31989747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14934 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|